Carregando...
Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
Purpose: Most prostate cancers (PCs) initially respond to androgen deprivation therapy (ADT), but eventually many PC patients develop castration resistant PC (CRPC). Currently, available drugs that have been approved for the treatment of CRPC patients are limited. Computational drug repositioning me...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6664029/ https://ncbi.nlm.nih.gov/pubmed/31396486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00661 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|